Skip to main content
Log in

Recombinant human growth hormone treatment of children following renal transplantation

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Nine growth-retarded renal allograft recipients received either thrice weekly or daily subcutaneous recombinant human growth hormone (rhGH) for 6–30 months. The annualized growth velocity for the initial year of rhGH treatment was significantly greater than that of the preceding year (2.5±2.1 vs 5.7±2.7;P<0.0001). There was no advancement in bone age greater than the increase in chronological age, no significant increase in the mean fasting serum glucose or insulin levels, nor significant decrease in the calculated creatinine clearance following rhGH treatment. However, two patients experienced rejection episodes following rhGH treatment indicating the potiental adverse consequences of the treatment on allograft function. This will require further delineation in prospective controlled studies. The serum insulin-like growth factor-1 levels significantly increased at 6 months (P<0.009) and 12 months (P<0.002) following rhGH treatment compared with baseline values. These preliminary data indicate that rhGH treatment may be effective in improving the growth velocity of growth-retarded renal allograft recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fine RN (1984) Growth in children with renal insufficiency. In: Nissenson AR, Fine RN, Gentile DE (eds) Clinical dialysis. Appleton and Lange, Norwalk, pp 661–670

    Google Scholar 

  2. Kleinknecht C, Broyer M, Huot D, Marti-Hennenberg C, Darois AM (1983) Growth and development of nondialyzed children with chronic renal failure. Kidney Int [Suppl 15]:S40–47

    Google Scholar 

  3. Potter DE (1987) Comparison of CAPD and hemodialysis in children. In: Fine RN (ed) Chronic ambulatory peritoneal dialysis (CAPD) and chronic cycling peritoneal dialysis (CCPD) in children. Martinus Nijhoff, Boston, pp 297–306

    Google Scholar 

  4. Chantler C, Broyer M, Donckerwolcke RA, Bryner H, Brunner FP, Jacobs C, Kramer P, Selwood NH, Wing AJ (1981) Growth and rehabilitation of long-term survivors of treatment for end-stage renal failure in childhood. Proc Eur Dial Transplant Assoc 18:329–342

    Google Scholar 

  5. Potter D, Feduska N, Nelzer J, Garovoy M, Hopper S, Duca R, Salvatierra O (1986) Twenty years of renal transplantation in children. Pediatrics 77:465–470

    Google Scholar 

  6. Diemen-Steenvoorde R van, Donckerwolcke RA, Brackel H, Wolff ED, Jong MCJW de (1987) Growth and sexual maturation in children after kidney transplantation. J Pediatr 110:351–356

    Google Scholar 

  7. Mehls O, Ritz E (1983) Skeletal growth in experimental uremia. Kidney Int [Suppl 15]:S33-S62

    Google Scholar 

  8. Mehls O, Ritz E, Hunziker EE, Eggli P, Heinrich U, Zapf J (1988) Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 33:45–52

    Google Scholar 

  9. Koch V, Lippe BM, Nelson PA, Boechat MI, Sherman BM, Fine RN (1989) Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr 115:365–371

    Google Scholar 

  10. Fine RN, Koch VH, Nelson PA, Boechat MI, Fine SE, Sherman BM, Lippe BH (1990) Recombinant human growth hormone (rhGH) treatment of children with renal insufficiency. Adv Nephrol 19:187–208

    Google Scholar 

  11. Tonshoff B, Mehls O, Schauer A, Heinrich U, Blum W, Ranke M (1989) Improvement of uremic growth failure by recombinant human growth hormone. Kidney Int 36 [Suppl 27]:S201-S204

    Google Scholar 

  12. Fass B, Lippe BM, Kaplan SA (1979) Relative usefulness of three growth hormone stimulation screening test. Am J Dis Child 133:931–933

    Google Scholar 

  13. Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL (1987) Serum concentrations of insulin-like growth factors (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 4:287–292

    Google Scholar 

  14. Foreman JW, Kainer G, Nakano M, Boyle F, Chan JCM (1989) Severe hypercalciuria: an unexpected result of concurrent use of 1,25-dihydroxyvitamin D3 and growth hormone in uremic rats. Pediatr Nephrol 3:C205

    Google Scholar 

  15. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford

    Google Scholar 

  16. Roche AF (1978) Growth assessment in abnormal children. Kidney Int 14:369–377

    Google Scholar 

  17. Hamil PVV (ed) (1977) Growths curves for children. DHEW publication No. (PHS) 78-1650. National Center for Health Statistics, Washington D.C.

    Google Scholar 

  18. Schwartz GJ, Haycock MB, Edelmann EM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263

    Google Scholar 

  19. Rees L, Rigden S, Preece M (1989) Treatment of short stature by growth hormone in children with renal disease. Pediatr Nephrol 3:C206

    Google Scholar 

  20. Guyda H, Dean H (1987) Intermittent versus continuous GH administration in growth hormone deficiency. Pediatr Adolesc Endocrinol 16:61–71

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fine, R.N., Yadin, O., Nelson, P.A. et al. Recombinant human growth hormone treatment of children following renal transplantation. Pediatr Nephrol 5, 147–151 (1991). https://doi.org/10.1007/BF00852873

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00852873

Key words

Navigation